CHF Solutions announced that it changed its name to Nuwellis to reflect its focus on pediatric care, critical care and heart failure fluid imbalance.
Eden Prairie, Minn.-based Nuwellis made the change effective on Tuesday, April 27, 2021, and, in conjunction with the name change, changed its ticker symbol on the Nasdaq from CHFS to NUWE, according to a news release.
Nuwellis is meant to be a reflection of the “new well” that the company believes signifies “better tomorrows” for patients, families and providers through the benefits of the company’s Aquadex system.
Aquadex, a fluid management system that uses ultrafiltration to restore fluid balance in patients experiencing fluid overload, most recently received FDA 510(k) clearance for use in pediatric patients weighing 20 kg or more. Beyond treating heart failure, the device can be of use in these situations with pediatric patients and in critical care, Nuwellis said.